Search Results 421-430 of 24155 for prostate cancer

  1. A Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS) - Mayo Clinic

    The primary purpose of this study is to assess progression-free survival of men who have oligometastatic prostate cancer after randomization to stereotactic ...

  2. Blood in semen - Mayo Clinic

    Prostate cancer: Does PSA level affect prognosis? What is prostate cancer? A Mayo Clinic expert explains · Prostate cancer prevention ...

  3. PSA and Red Wine: Mayo Clinic Radio Health Minute

    Could a little red wine lower your risk of prostate cancer? In this Mayo Clinic Radio Health Minute, Dr. Jeffrey Karnes says maybe. To listen, click the ...

  4. Radiation therapy - Mayo Clinic

    Very rarely, a new cancer may develop years or decades after cancer treatment. ... Prostate cancer: screening and treatment options May 19, 2025, 06:05 p.m. ...

  5. Prostate Imaging Using MRI +/- Contrast Enhancement - Mayo Clinic

    Participation eligibility · Men at least 18 years of age referred with clinical suspicion of prostate cancer. · Serum PSA ≤ 20ng/ml. · Fit to undergo all ...

  6. Living With Cancer: Ovary removal surgery - Mayo Clinic News Network

    Prostate cancer brachytherapy treats cancer by delivering radiation directly to the prostate, minimizing radiation to surrounding tissue. The radioactive seeds ...

  7. Testing Whether The Addition Of Carboplatin Chemotherapy To Cabazitaxel Chemotherapy Will Improve Outcomes Compared To Cabazitaxel Alone In People With Castrate-Resistant Prostate Cancer That Has Spread Beyond The Prostate To Other Parts Of The Body - Mayo Clinic

    Giving carboplatin with the standard of care chemotherapy drug cabazitaxel may be better at treating metastatic castrate-resistant prostate cancer.

  8. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    Histologically or cytologically confirmed prostate cancer (individuals with primary neuroendocrine carcinoma of prostate are excluded); Must have documented ...

  9. Eugene D. Kwon, M.D. - Doctors and Medical Staff - Mayo Clinic

    MemberProgram for Breast and Prostate Cancer, Specialized Programs of Research Excellence, National Cancer Institute. 2000 - 2003. Co-ChairDOD Breast Cancer ...

  10. Living With Cancer: What do you know about cervical cancer?

    In practice, though, most cases of prostate cancer metastasis occur in the lymph nodes and the bones. Learn more from Dr. Erik Castle, a Mayo Clinic urologist.